Recurrent Clostridium difficile infection treated with bezlotoxumab in a liver transplant patient

Gastroenterol Hepatol. 2021 Dec;44(10):720-721. doi: 10.1016/j.gastrohep.2020.09.015. Epub 2020 Oct 22.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Antibodies, Monoclonal / therapeutic use*
  • Broadly Neutralizing Antibodies / therapeutic use*
  • Clostridioides difficile*
  • Clostridium Infections / therapy*
  • Humans
  • Male
  • Middle Aged
  • Recurrence
  • Vancomycin / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Antibodies, Monoclonal
  • Broadly Neutralizing Antibodies
  • bezlotoxumab
  • Vancomycin